Neovasc Inc. Cash and Short Term Investments

Cash and Short Term Investments of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Cash and Short Term Investments growth rates and interactive chart. Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities. Cash and short term investments are considered very liquid assets.


Highlights and Quick Summary

  • Cash and Short Term Investments for the quarter ending March 31, 2022 was $44.2 Million (a -13.84% decrease compared to previous quarter)
  • Year-over-year quarterly Cash and Short Term Investments decreased by -30.13%
  • Annual Cash and Short Term Investments for 2021 was $51.3 Million (a 295.01% increase from previous year)
  • Annual Cash and Short Term Investments for 2020 was $13 Million (a 145.79% increase from previous year)
  • Annual Cash and Short Term Investments for 2019 was $5.28 Million (a -43.12% decrease from previous year)
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Cash and Short Term Investments of Neovasc Inc.

Most recent Cash and Short Term Investmentsof NVCN including historical data for past 10 years.

Interactive Chart of Cash and Short Term Investments of Neovasc Inc.

Neovasc Inc. Cash and Short Term Investments for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $44.16
2021 $51.26 $55.69 $63.21 $70.32 $51.26
2020 $12.98 $14.03 $11.45 $7.04 $12.98
2019 $5.29 $11.4 $18.34 $12.12 $5.28
2018 $9.24 $14.49 $20.08 $12.26 $9.28
2017 $17.51 $76.59 $81.77 $86.28 $17.55
2016 $92.95 $36.28 $46.9 $92.95
2015 $55.03 $64.38 $76.25 $81.92 $55.03
2014 $15.53 $19.96 $23.54 $24.7 $15.54
2013 $3.3 $4.01 $5.34 $4.82 $3.3
2012 $5.86 $2.03 $2.59 $3.18 $5.86
2011 $3.9 $3.9

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.